MENU
HELP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cybin (HELP) Ownership - Who owns Cybin?

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways... Show more

Profile

Industry
N/A
Address
100 King Street West
Phone
+1 866 292-4601
Employees
50
Web
https://www.helus.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
943.68M
P/E Ratio
N/A
Total Cash
166.37M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.80
Dividend Yield
N/A
Total Cash/Share
2.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
HELP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
100 King Street West
Phone
+1 866 292-4601
Employees
50
Web
https://www.helus.com
Who owns Cybin? HELP symbol Ownership - Tickeron.com